{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T05:28:00Z","timestamp":1671859680275},"reference-count":15,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":15,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1111\/dth.12272","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T07:02:53Z","timestamp":1439794973000},"page":"15-18","source":"Crossref","is-referenced-by-count":1,"title":["Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine"],"prefix":"10.1155","volume":"29","author":[{"given":"Monika","family":"Heisig","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology; Wroclaw Medical University; Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Maj","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology; Wroclaw Medical University; Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology; Wroclaw Medical University; Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Reich","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Allergology; Wroclaw Medical University; Wroclaw Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2015,8,17]]},"reference":[{"key":"10.1111\/dth.12272-BIB0001|dth12272-cit-0001","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jdv.12743","article-title":"Folliculotropic mycosis fungoides: clinicopathological analysis of 17 patients","volume":"29","author":"Marschalko","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12272-BIB0002|dth12272-cit-0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4137\/CCRep.S15724","article-title":"Mycosis fungoides: case report and literature review","volume":"7","author":"Akinbami","year":"2014","journal-title":"Clin Med Insights Case Rep"},{"key":"10.1111\/dth.12272-BIB0003|dth12272-cit-0003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2009.03.014","article-title":"Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases","volume":"62","author":"Muniesa","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12272-BIB0004|dth12272-cit-0004","first-page":"41","article-title":"New trends in the management of mycosis fungoides and Sezary syndrome","volume":"26","author":"Batycka-Baran","year":"2009","journal-title":"Post Dermatol Alergol"},{"key":"10.1111\/dth.12272-BIB0005|dth12272-cit-0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.seminhematol.2013.11.004","article-title":"Novel therapeutic strategies for cutaneous T-cell lymphoma in advanced stages","volume":"51","author":"Kun","year":"2014","journal-title":"Semin Hematol"},{"key":"10.1111\/dth.12272-BIB0006|dth12272-cit-0006","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous task force of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1111\/dth.12272-BIB0007|dth12272-cit-0007","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the international society for cutaneous lymphomas, the United Stated Cutaneous Lymphoma Consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/dth.12272-BIB0008|dth12272-cit-0008","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-Eclassification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/dth.12272-BIB0009|dth12272-cit-0009","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2133.2004.06028.x","article-title":"Syringotropic cutaneous T-cell lymphoma: an immunophenotypic and genotypic study of five cases","volume":"151","author":"Thein","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/dth.12272-BIB0010|dth12272-cit-0010","first-page":"491","article-title":"Diagnosis and management of mycosis fungoides","volume":"24","author":"Galper","year":"2010","journal-title":"Oncology"},{"key":"10.1111\/dth.12272-BIB0011|dth12272-cit-0011","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0190-9622(88)70223-6","article-title":"Topical mechlorethamine therapy for early stage mycosis fungoides","volume":"19","author":"Ramsay","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12272-BIB0012|dth12272-cit-0012","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archderm.139.2.165","article-title":"Topical nitrogen mustard in the management of mycosis fungoides: Update of the Stanford experience","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/dth.12272-BIB0013|dth12272-cit-0013","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0190-9622(90)70112-U","article-title":"Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patients","volume":"22","author":"Zackheim","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12272-BIB0014|dth12272-cit-0014","first-page":"3","article-title":"Targeting cell cycle regulators in hematologic malignancies","volume":"9","author":"Aleem","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1111\/dth.12272-BIB0015|dth12272-cit-0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/14656566.2.6.929","article-title":"Nucleoside analogues in the treatment of haematological malignancies","volume":"2","author":"Johnson","year":"2001","journal-title":"Expert Opin Pharmacother"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12272","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12272\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:55:29Z","timestamp":1671818129000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12272"}},"subtitle":["MF treated with topical cytarabine and carmustine"],"short-title":[],"issued":{"date-parts":[[2015,8,17]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12272","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8,17]]}}}